Pharma Equity Group A/S
PEG.CO · CPH
6/30/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Revenue | – | DKK 0 | DKK 0 | DKK 0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | – | DKK 0 | DKK 124 | DKK 124 |
| Gross Profit | – | DKK 0 | -DKK 124 | -DKK 124 |
| % Margin | – | – | – | – |
| R&D Expenses | – | DKK 2,803 | DKK 1,783 | DKK 1,843 |
| G&A Expenses | – | DKK 1,427 | DKK 3,459 | DKK 3,145 |
| SG&A Expenses | – | DKK 1,427 | DKK 3,335 | DKK 3,021 |
| Sales & Mktg Exp. | – | DKK 0 | DKK 0 | DKK 0 |
| Other Operating Expenses | – | -DKK 1 | DKK 0 | DKK 0 |
| Operating Expenses | – | DKK 4,229 | DKK 5,118 | DKK 4,864 |
| Operating Income | – | -DKK 4,229 | -DKK 5,241 | -DKK 4,988 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | – | -DKK 812 | -DKK 1,906 | -DKK 1,275 |
| Pre-Tax Income | – | -DKK 5,041 | -DKK 7,147 | -DKK 6,263 |
| Tax Expense | – | -DKK 396 | -DKK 401 | -DKK 402 |
| Net Income | – | -DKK 4,645 | -DKK 6,746 | -DKK 5,861 |
| % Margin | – | – | – | – |
| EPS | – | -0.006 | -0.006 | -0.006 |
| % Growth | – | 0% | -5.3% | – |
| EPS Diluted | – | -0.006 | -0.006 | -0.006 |
| Weighted Avg Shares Out | – | 1,022,949 | 1,022,949 | 1,022,949 |
| Weighted Avg Shares Out Dil | – | 1,022,949 | 1,022,949 | 1,022,949 |
| Supplemental Information | – | – | – | – |
| Interest Income | – | DKK 13 | DKK 0 | DKK 0 |
| Interest Expense | – | DKK 820 | DKK 1,906 | DKK 1,275 |
| Depreciation & Amortization | – | -DKK 137 | DKK 124 | DKK 124 |
| EBITDA | – | -DKK 4,221 | -DKK 5,117 | -DKK 4,864 |
| % Margin | – | – | – | – |